UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~Washington~~WASHINGTON, DC 20549

FORM 8-K

~~CURRENT~~Current ~~REPORT~~Report Pursuant to Section 13 or 15(d) of

~~Pursuant~~The toSecurities ~~Section 13~~Exchange orAct ~~15(d)~~of 1934

Date of ~~the~~Report ~~Securities~~(Date ~~Exchange~~of ~~Act~~earliest ofevent ~~1934~~reported): September 11, 2024

Date of Report (Date of earliest event reported): August 28, 2024

Kewaunee Scientific Corporation

(Exact name of registrant as specified in its charter)

Delaware

~~0-5286~~

~~38-0715562~~

0-5286

38-0715562

(State or other jurisdictionof incorporation)

(CommissionFile Number)

(IRS. EmployerIdentification No.)

(State or other jurisdiction ofincorporation or organization)

(Commission FileNumber)

(IRS EmployerIdentification No.)

2700 West Front Street
Statesville, North Carolina		28677
(Address of principal executive offices)		(Zip Code)

2700 West Front Street

~~Registrant’s telephone number~~Statesville, ~~including~~NC ~~area code: 704-873-7202~~28677

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (704) 873-7202

N/A

(Former name or former address, if changed since last report.)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

~~TradingSymbol(s)~~

~~Name of each exchangeon which registered~~

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $2.50 par value

~~KEQU~~

~~The Nasdaq Global Market~~

KEQU

The Nasdaq Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the ~~Exchange Act. ☐~~

~~Item~~Exchange 5Act.~~07 Submission of Matters to a Vote of Security Holders.~~ ☐

~~(a) and (b) On August~~Item ~~28,~~2.02 ~~2024,~~Results ~~Kewaunee Scientific Corporation (the “Company”) held its Annual Meeting~~ of ~~Shareholders~~Operations ~~(the~~and ~~“Annual~~Financial ~~Meeting”). At the Annual Meeting, the Company’s shareholders voted on the matters set forth below.~~ Condition

~~1. The~~On ~~nominee~~September ~~named~~11, ~~below~~2024, ~~was~~Kewaunee ~~re-elected~~Scientific asCorporation issued a ~~Class II~~press ~~director~~release announcing its financial results for athe ~~three-~~first quarter of fiscal year ~~term~~2025. A copy of the press release is furnished as ~~follows:~~Exhibit 99.1 to this Current Report on Form 8-K.

Name of Nominee		For		Withheld		Non-Votes
Mr. Keith M. Gehl		1,404,874		273,145		739,723

Item 9.01. Financial Statements and Exhibits.

~~2. The~~(d) ~~appointment of the independent registered public accounting firm of Forvis Mazars, LLP as the Company’s independent auditors for fiscal year 2025 was ratified as follows:~~ Exhibits

For	Against	Abstained
Exhibit No.			Description
2,414,204	2,479	1,059
99.1			Press Release of Kewaunee Scientific Corporation dated September 11, 2024.
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

3In accordance with General Instruction B. ~~The~~2 ~~compensation~~of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the ~~Company’s~~Securities ~~named~~Exchange ~~executive~~Act ~~officers~~of ~~was~~1934, ~~approved~~as onamended an(the ~~advisory~~"Exchange ~~basis~~Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as ~~follows:~~amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

For		Against		Abstained		Non-Votes
1,440,693		3,005		234,321		739,723

SIGNATURE

~~Signature~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	KEWAUNEE SCIENTIFIC CORPORATION (Registrant)

Date: September 11, 2024	By	/s/ Donald T. Gardner III
		Donald T. Gardner III
		Vice President, Finance
		Chief Financial Officer

		(Registrant) Kewaunee Scientific Corporation
Date: August 29, 2024		/s/ Donald T. Gardner III
		Donald T. Gardner III
		Vice President, Finance and Chief Financial Officer

Filing Compare · KEWAUNEE SCIENTIFIC CORP /DE/